DermaMedics
Oklahoma City, Oklahoma, United States · Founded 2010
About DermaMedics
DermaMedics is a pharmaceutical skin care company specializing in the development of novel topical therapeutics for the dermatology market. DermaMedics has broad expertise in skin research, drug discovery, and topical product formulation. The company is using this expertise to identify novel phytochemicals that can gently and effectively treat inflammatory skin problems and skin aging without the side effects associated with topical corticosteroids and immunosuppressive drugs. DermaMedics’ research has led to the discovery of Therosol®, a botanically-derived chemical compound with remarkable anti-inflammatory and anti-aging activities. Clinical studies have shown that topical Therosol® is effective in treating psoriasis, eczema, acne, and rosacea, and can completely prevent radiation burns in cancer patients.
Company Facts
- Founded: 2010
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.5M
- Last round: Series Unknown (Apr 2012)
- Website: https://www.dermamedics.com/
- Phone: +1 4053 198 139
Industries & Categories
Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/dermamedics-2533069 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.